| NCT ID | NCT06359652 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Chicago |
| Condition | Thoracic |
| Study Type | INTERVENTIONAL |
| Enrollment | 100 participants |
| Start Date | 2024-04-11 |
| Primary Completion | 2029-04 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 100 participants in total. It began in 2024-04-11 with a primary completion date of 2029-04.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The purpose of this study will be to implement and evaluate a prehab program for pre-frail and frail adults who need to undergo thoracic surgery. The study team hypothesizes using an implementation framework will increase the reach, effectiveness, adoption, and implementation of the prehab program.
Eligibility Criteria
Inclusion Criteria: * Age ≥ 18, of any racial or ethnic origin * Will be undergoing elective thoracic surgery lung resection using thoracic approach (thoracotomy, Video-assisted thoracoscopic surgery (VATS), Robotic-Assisted Thoracic Surgery (RATS) * Able to complete baseline evaluations at time of enrollment Exclusion Criteria: * Unable to give informed consent * Unable to read/speak English * Age \<17
Contact & Investigator
Maria Madariaga, MD
PRINCIPAL INVESTIGATOR
University of Chicago
Frequently Asked Questions
Who can join the NCT06359652 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Thoracic. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06359652 currently recruiting?
Yes, NCT06359652 is actively recruiting participants. Contact the research team at mlmadariaga@bsd.uchicago.edu for enrollment information.
Where is the NCT06359652 trial being conducted?
This trial is being conducted at Chicago, United States.
Who is sponsoring the NCT06359652 clinical trial?
NCT06359652 is sponsored by University of Chicago. The principal investigator is Maria Madariaga, MD at University of Chicago. The trial plans to enroll 100 participants.